These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30468736)

  • 1. Improving TCR affinity on 293T cells.
    Ohta R; Demachi-Okamura A; Akatsuka Y; Fujiwara H; Kuzushima K
    J Immunol Methods; 2019 Mar; 466():1-8. PubMed ID: 30468736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3.
    Chlewicki LK; Holler PD; Monti BC; Clutter MR; Kranz DM
    J Mol Biol; 2005 Feb; 346(1):223-39. PubMed ID: 15663940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutations.
    Shen M; Chen S; Han X; Hao Y; Wang J; Li L; Chen T; Wang B; Zou L; Zhang T; Zhang W; Han X; Wang W; Yu H; Li K; Liu S; Jin A
    Cancer Immunol Immunother; 2024 Jun; 73(8):150. PubMed ID: 38832948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of T cell receptor-engineered T cells targeting the sarcoma-associated antigen papillomavirus binding factor.
    Hamada S; Tsukahara T; Watanabe Y; Murata K; Mizue Y; Kubo T; Kanaseki T; Hirohashi Y; Emori M; Nakatsugawa M; Teramoto A; Yamashita T; Torigoe T
    Cancer Sci; 2024 Jan; 115(1):24-35. PubMed ID: 37879364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancer.
    Scholten KB; Schreurs MW; Ruizendaal JJ; Kueter EW; Kramer D; Veenbergen S; Meijer CJ; Hooijberg E
    Clin Immunol; 2005 Feb; 114(2):119-29. PubMed ID: 15639645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity.
    Casanova JL; Cerottini JC; Matthes M; Necker A; Gournier H; Barra C; Widmann C; MacDonald HR; Lemonnier F; Malissen B; Maryanski JL
    J Exp Med; 1992 Aug; 176(2):439-47. PubMed ID: 1380061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid identification of CMV-specific TCRs via reverse TCR cloning system based on bulk TCR repertoire data.
    Hong CH; Pyo HS; Baek IC; Kim TG
    Front Immunol; 2022; 13():1021067. PubMed ID: 36466875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
    Hoffmann TK; Donnenberg VS; Friebe-Hoffmann U; Meyer EM; Rinaldo CR; DeLeo AB; Whiteside TL; Donnenberg AD
    Cytometry; 2000 Dec; 41(4):321-8. PubMed ID: 11084618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia.
    Miyazaki Y; Fujiwara H; Asai H; Ochi F; Ochi T; Azuma T; Ishida T; Okamoto S; Mineno J; Kuzushima K; Shiku H; Yasukawa M
    Blood; 2013 Jun; 121(24):4894-901. PubMed ID: 23641014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The characteristics of anti-B-cell malignance cytotoxic T lymphocytic clones induced by lymphoma relative peptides].
    Guo XL; Zhu P; Zhu X; Liu J; Ou Y; Du JW
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1476-80. PubMed ID: 16061026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor tetramer binding or the lack there of does not necessitate antigen reactivity in T-cell receptor transduced T cells.
    Lyons GE; Roszkowski JJ; Man S; Yee C; Kast WM; Nishimura MI
    Cancer Immunol Immunother; 2006 Sep; 55(9):1142-50. PubMed ID: 16374636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors.
    Dillard P; Casey N; Pollmann S; Vernhoff P; Gaudernack G; Kvalheim G; Wälchli S; Inderberg EM
    Oncoimmunology; 2021; 10(1):1936757. PubMed ID: 34235003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy.
    Ochi T; Nakatsugawa M; Chamoto K; Tanaka S; Yamashita Y; Guo T; Fujiwara H; Yasukawa M; Butler MO; Hirano N
    Cancer Immunol Res; 2015 Sep; 3(9):1070-81. PubMed ID: 25943533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells.
    Lyons GE; Moore T; Brasic N; Li M; Roszkowski JJ; Nishimura MI
    Cancer Res; 2006 Dec; 66(23):11455-61. PubMed ID: 17145893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-Cell Receptor (TCR) Clonotype-Specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T-Cell Clones Is Not Mediated by TCR Alone.
    Flerin NC; Chen H; Glover TD; Lamothe PA; Zheng JH; Fang JW; Ndhlovu ZM; Newell EW; Davis MM; Walker BD; Goldstein H
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells.
    Spear TT; Wang Y; Foley KC; Murray DC; Scurti GM; Simms PE; Garrett-Mayer E; Hellman LM; Baker BM; Nishimura MI
    Cancer Immunol Immunother; 2017 Nov; 66(11):1411-1424. PubMed ID: 28634816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules.
    Hansen BE; Rasmussen AH; Jakobsen BK; Ryder LP; Svejgaard A
    Tissue Antigens; 2007 Jul; 70(1):42-52. PubMed ID: 17559580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of a natural WT1 epitope by a modified WT1 peptide-specific T-cell receptor.
    Tamanaka T; Oka Y; Fujiki F; Tsuboi A; Katsuhara A; Nakajima H; Hosen N; Nishida S; Lin YH; Tachino S; Akatsuka Y; Kuzushima K; Oji Y; Kumanogoh A; Sugiyama H
    Anticancer Res; 2012 Dec; 32(12):5201-9. PubMed ID: 23225417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of human p53-overexpressing tumor cells by an HLA A*0201-restricted murine T-cell receptor expressed in Jurkat T cells.
    Liu X; Peralta EA; Ellenhorn JD; Diamond DJ
    Cancer Res; 2000 Feb; 60(3):693-701. PubMed ID: 10676655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unpredicted phenotypes of two mutants of the TcR DMF5.
    Tadesse FG; Mensali N; Fallang LE; Walseng E; Yang W; Olweus J; Wälchli S
    J Immunol Methods; 2015 Oct; 425():37-44. PubMed ID: 26079729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.